Valuation: Safe Fertility Group

Market Cap 1.61B 48.57M 42.45M 39.89M 36.41M 68.33M 4.64B 68.34M 479M 185M 2.37B 182M 178M 7.64B P/E 2026 *
12.6x
P/E 2027 * 12x
Enterprise Value 1.61B 48.57M 42.45M 39.89M 36.41M 68.33M 4.64B 68.34M 479M 185M 2.37B 182M 178M 7.64B EV / Sales 2026 *
2.31x
EV / Sales 2027 * 2.22x
Free-Float
23.1%
Yield 2026 *
6.98%
Yield 2027 * 6.98%
08-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-08 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02-20 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2025 CI
02-19 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 22, 2026 CI
11-07 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
07/08/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
07/05/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
29/04/25 Safe Fertility Group Public Company Limited Approves Dividend for the Year 2024, Payable on 23 May 2025 CI
20/02/25 Safe Fertility Group Public Company Limited Reports Earnings Results for the Full Year Ended December 31, 2024 CI
20/02/25 Safe Fertility Group Public Company Limited announces Annual dividend, payable on May 23, 2025 CI
07/11/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
02/11/24 125,378,468 Ordinary Shares of Safe Fertility Group Public Company Limited are subject to a Lock-Up Agreement Ending on 2-NOV-2024. CI
07/08/24 Safe Fertility Group Public Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
1 week-0.93%
3 months-5.36%
6 months-12.40%
Current year-16.54%
1 week 5.25
Extreme 5.25
5.35
1 month 5.15
Extreme 5.15
5.45
Current year 5.15
Extreme 5.15
6.9
1 year 5.15
Extreme 5.15
7.75
3 years 5.15
Extreme 5.15
23.7
5 years 5.15
Extreme 5.15
23.7
10 years 5.15
Extreme 5.15
23.7
Manager TitleAgeSince
Chief Executive Officer 60 01/01/2007
Director of Finance/CFO 45 -
Chief Operating Officer 59 20/07/2009
Director TitleAgeSince
Director/Board Member 60 01/01/2007
Director/Board Member 59 20/07/2009
Director/Board Member 59 -
Date Insider Type Main position Quantity % Market Cap. Importance
1/20/26 A Buy

Chief Executive Officer

10,000 0.0033%
1/19/26 A Buy

Chief Executive Officer

62,000 0.0204%
1/12/26 A Buy

Chief Executive Officer

27,500 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.93%-26.90% - 48.57M
-0.57%-7.82%+15.93%+22.42% 111B
+2.85%+3.37%+7.58%+73.67% 94.85B
-0.90%+1.17%-1.82%+49.82% 29.37B
-4.13%-4.99%+27.11%+90.12% 25.91B
-0.09%-1.22%-10.43%-3.03% 21.2B
+0.42%+0.46%+35.04%+286.92% 21.1B
+0.76%+3.98%-7.91%+45.38% 16.37B
-0.47%-2.20%-10.72%-6.79% 11.92B
+0.76%-3.76%+40.08%+86.12% 11.72B
Average +0.03%-1.07%+6.80%+71.63% 34.39B
Weighted average by Cap. +0.84%-1.97%+11.26%+60.91%

Financials

2026 *2027 *
Net sales 698M 21.05M 18.39M 17.29M 15.77M 29.61M 2.01B 29.61M 207M 80.05M 1.03B 79.03M 77.3M 3.31B 727M 21.92M 19.16M 18M 16.43M 30.84M 2.1B 30.84M 216M 83.38M 1.07B 82.32M 80.51M 3.45B
Net income 128M 3.86M 3.37M 3.17M 2.89M 5.43M 369M 5.43M 38.04M 14.68M 188M 14.49M 14.18M 607M 135M 4.07M 3.56M 3.34M 3.05M 5.73M 389M 5.73M 40.12M 15.48M 199M 15.29M 14.95M 641M
Net Debt - -
Logo Safe Fertility Group
Safe Fertility Group Public Company Limited is a Thailand-based company engaged in providing an obstetrics and gynecology hospital. It is also engaged in the business of medical laboratory and cosmetic dermatology. The Company's segments are Obstetrics and Gynecology Hospital and Medical Laboratory, and Cosmetic Dermatology. Its services include In Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI), Intrauterine Insemination (IUI), Egg Freezing, Embryo Transfer, Sperm Freezing, Sperm Analysis, Magnetic Activated Cell Sorting (MACS) Sperm, Intracytoplasmic Morphologically Selected Sperm Injection (IMSI), Testicular Sperm Extraction/Percutaneous Epididymal Sperm Aspiration (TESE/PESA), Couple Check-Up, EmbryoScope Plus, Preimplantation Genetic Testing for Aneuploidy (PGT-A), Preimplantation Genetic Testing for Monogenic Disorders (PGT-M), and Acupuncture. The Company's subsidiaries include Next Generation Genomics Co., Ltd., and Safe Wellness Company Limited.
Employees
-
Date Price Change Volume
22/09/26 THB 5.300 0.00% 122,776
21/09/26 THB 5.300 +0.95% 167,934
18/09/26 THB 5.250 -0.94% 42,200
17/09/26 THB 5.300 0.00% 20,000
16/09/26 THB 5.300 -0.93% 170,000
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
5.300THB
Average target price
9.800THB
Spread / Average Target
+84.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SAFE Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!